Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus.
about
Healthcare quality in systemic lupus erythematosus: using Donabedian’s conceptual framework to understand what we knowPregnancy Outcomes in Chinese Patients with Systemic Lupus Erythematosus (SLE): A Retrospective Study of 109 PregnanciesQuality of care for incident lupus nephritis among Medicaid beneficiaries in the United StatesQuality of care in systemic lupus erythematosus: the association between process and outcome measures in the Lupus Outcomes Study.Systemic lupus erythematosus: review of synthetic drugs.Methotrexate utilization in Rheumatoid arthritis. A register-based cohort-study of treatment re-starts after gabs of at least 90 daysHydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 PhosphorylationQuality of care in systemic lupus erythematosus: application of quality measures to understand gaps in care.Assessing the need for improved access to rheumatology care: a survey of Massachusetts community health center medical directors.The role of antimalarial agents in the treatment of SLE and lupus nephritis.New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.The treatment of systemic lupus proliferative nephritis.Comparison of systemic lupus erythematosus (SLE) patients managed early after diagnosis in specialty versus community care clinics.Hydroxychloroquine retinopathy.Drugs used in incident systemic lupus erythematosus - results from the Finnish nationwide register 2000-2007.Antimalarials in the treatment of systemic lupus erythematosus: a registry-based cohort study in Denmark.Validation of the Japanese version of the Systemic Lupus Activity Questionnaire that includes physician-based assessments in a large observational cohort.The Cutaneous Spectrum of Lupus Erythematosus.
P2860
Q24613829-E950A69A-DA08-448F-9380-242C698E6847Q33434059-963541F9-DC58-4C08-ABA1-031E260D6DF5Q33945242-9552AEC9-B86D-4EF8-939F-94F409DF2B9FQ33981158-7FBAAE62-CB4C-4A5F-906D-BC4676F596D7Q34498515-DF2BB28C-E578-4900-9AB4-25491F9DD137Q35761884-9D597F70-BCF9-4A59-89AE-725073F556D8Q35860938-4076276F-9F5B-462B-9E6F-55B2065A27A3Q36243472-6C283FDE-D4D2-4B55-A04C-F4CABB48FA89Q37343796-FCA7F01C-A1B0-445A-BF14-A00AEA068218Q37947108-6A0ED472-0C27-4B4D-A061-57BCAE09A04FQ38026787-B9D12DCC-B02E-4187-9423-9D2116F3FE12Q38062341-FC3B9A47-D8E3-482E-AE1D-29BA617E435BQ38739246-A365A9F1-A38D-4AEF-A448-81BA27C1C029Q39172826-F47E25D0-CB92-4E3E-A1B8-3CF45B042648Q40047389-E43E7AD0-E7DF-41DA-A697-D3E62B5B421AQ41919852-8823D72F-291A-4937-A2FD-76611ADD2E59Q47960264-40ED95F3-EA47-44C2-A4A8-A223CF5CCEEBQ48332079-5145369E-C8F3-45FA-A817-35CA8BD13AB6
P2860
Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hydroxychloroquine treatment i ...... systemic lupus erythematosus.
@ast
Hydroxychloroquine treatment i ...... systemic lupus erythematosus.
@en
Hydroxychloroquine treatment i ...... systemic lupus erythematosus.
@nl
type
label
Hydroxychloroquine treatment i ...... systemic lupus erythematosus.
@ast
Hydroxychloroquine treatment i ...... systemic lupus erythematosus.
@en
Hydroxychloroquine treatment i ...... systemic lupus erythematosus.
@nl
prefLabel
Hydroxychloroquine treatment i ...... systemic lupus erythematosus.
@ast
Hydroxychloroquine treatment i ...... systemic lupus erythematosus.
@en
Hydroxychloroquine treatment i ...... systemic lupus erythematosus.
@nl
P2093
P2860
P356
P1476
Hydroxychloroquine treatment i ...... systemic lupus erythematosus.
@en
P2093
Edward Yelin
Gabriela Schmajuk
Jinoos Yazdany
Laura Trupin
P2860
P304
P356
10.1002/ACR.20002
P577
2010-03-01T00:00:00Z